Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma 2Sarcoma 1Recurrence 1Peripheral Nervous System Diseases 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Malignant mesenchymal tumor 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Liposarcoma 1Hodgkin Disease 1Hemangiosarcoma 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Colorectal Neoplasms 1Chondrosarcoma 1Breast Neoplasms 1

Interventions

plerixafor 1pazopanib 1lorukafusp alfa 1liposomal doxorubicin 1imetelstat 1Temozolomide 1Pentetic Acid 1Palliative Care 1Nutritional Support 1Minocycline 1MAGEA3 protein, human 1MAGEA1 protein, human 1Heparin 1Glutamine 1Gemcitabine 1GRN163L peptide 1Filgrastim 1Erlotinib Hydrochloride 1Electroacupuncture 1Docetaxel 1Dexamethasone 1Celecoxib 1Calcium Carbonate 1Analgesia 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Osteosarcoma × Glutamine × Clear all
NCT00334984 2013-07-11

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Children's Oncology Group

Phase NA Withdrawn
Sarcoma

Malignant mesenchymal tumor, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Osteosarcoma, Dermatofibrosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡